UTHR United Therapeutics Corp

United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.

$238.03  +2.39 (1.01%)
As of 07/01/2022 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/09/2001
Outstanding shares:  45,299,512
Average volume:  526,130
Market cap:   $10,794,420,714
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2430412
Valuation   (See tab for details)
PE ratio:   15.53
PB ratio:   2.56
PS ratio:   6.10
Return on equity:   16.46%
Net income %:   38.87%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy